Role of PKC and ERK Signaling in Epidermal Blistering and Desmosome Regulation in Pemphigus.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 09 09 2019
accepted: 25 11 2019
entrez: 24 12 2019
pubmed: 24 12 2019
medline: 5 11 2020
Statut: epublish

Résumé

Desmosomes reinforce cohesion of epithelial cells at the interface between adjacent cells. They include the cadherin-type adhesion molecules desmoglein 1 (Dsg1) and Dsg3. Pemphigus vulgaris (PV) is an autoimmune disease in which circulating autoantibodies (PV-IgG) targeting Dsg1 and 3 cause characteristic epidermal blister formation. It has been shown that PV-IgG binding induced activation of kinases such as ERK and PKC, and inhibition of these signaling pathways prevented loss of cell cohesion in cell cultures. However, the role of Erk and PKC in blister formation and regulation of desmosome ultrastructure in human skin are unknown. Accordingly, we assessed the role of PKC and ERK signaling pathways in blister formation and regulation of desmosome ultrastructure in human epidermis. Here we performed electron microscopy analyses using human skin explants injected with PV-IgG together with inhibitors for PKC or ERK signaling. Inhibition of PKC was not effective to prevent suprabasal blister formation or ultrastructural alterations of desmosomes. In contrast, inhibition of ERK signaling significantly ameliorated blister formation and decrease in the number of desmosomes whereas shortening and splitting of desmosomes and keratin filament insertion were not different from samples treated with PV-IgG alone. However, apical desmosomes between basal and suprabasal cells remained unaltered when ERK signaling was inhibited. Therefore, our results show that inhibition of ERK but not PKC signaling appears to be effective to ameliorate blistering and alterations of desmosome ultrastructure triggered by PV-IgG in human skin.

Identifiants

pubmed: 31867019
doi: 10.3389/fimmu.2019.02883
pmc: PMC6910072
doi:

Substances chimiques

Protein Kinase C EC 2.7.11.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2883

Informations de copyright

Copyright © 2019 Egu, Kugelmann and Waschke.

Références

J Invest Dermatol. 2008 Mar;128(3):738-40
pubmed: 17928890
Exp Dermatol. 2009 Sep;18(9):771-80
pubmed: 19552768
J Invest Dermatol. 1985 Jan;84(1):41-6
pubmed: 3965577
Front Immunol. 2019 Apr 04;10:626
pubmed: 31024527
J Invest Dermatol. 2004 May;122(5):1145-53
pubmed: 15140217
J Invest Dermatol. 2015 Jul;135(7):1763-1770
pubmed: 25789704
Front Immunol. 2018 Apr 19;9:692
pubmed: 29755451
Clin Rev Allergy Immunol. 2018 Feb;54(1):1-25
pubmed: 29313220
J Clin Invest. 2013 Apr;123(4):1556-70
pubmed: 23524970
J Invest Dermatol. 2007 Apr;127(4):775-81
pubmed: 17195016
J Invest Dermatol. 2018 Jan;138(1):32-37
pubmed: 29037765
Br J Dermatol. 2004 Sep;151(3):565-70
pubmed: 15377341
Autoimmunity. 2014 Mar;47(2):134-40
pubmed: 24328683
Am J Pathol. 2011 Oct;179(4):1905-16
pubmed: 21864491
Front Immunol. 2018 Feb 01;9:136
pubmed: 29449846
Front Immunol. 2019 Apr 17;10:770
pubmed: 31057535
J Invest Dermatol. 1995 Sep;105(3):329-33
pubmed: 7665907
J Invest Dermatol. 2016 Jan;136(1):59-66
pubmed: 26763424
Sci Rep. 2017 Jun 15;7(1):3579
pubmed: 28620161
J Cell Biol. 2009 Jun 29;185(7):1243-58
pubmed: 19546243
N Engl J Med. 2006 Oct 26;355(17):1800-10
pubmed: 17065642
J Biol Chem. 2008 Jun 27;283(26):18303-13
pubmed: 18434319
J Cell Biol. 2006 Dec 4;175(5):721-7
pubmed: 17130286
J Biol Chem. 2005 Jun 24;280(25):23778-84
pubmed: 15840580
Exp Dermatol. 2013 Feb;22(2):125-30
pubmed: 23362871
Br J Dermatol. 2019 Jun 19;:null
pubmed: 31218663
Curr Opin Cell Biol. 2005 Oct;17(5):559-64
pubmed: 16098726
J Biol Chem. 2007 May 4;282(18):13804-12
pubmed: 17344213
Front Immunol. 2019 May 24;10:1128
pubmed: 31178865
Biochim Biophys Acta. 2008 Mar;1778(3):572-87
pubmed: 17854763
J Invest Dermatol. 1997 Apr;108(4):482-7
pubmed: 9077478
Histochem Cell Biol. 2008 Jul;130(1):21-54
pubmed: 18386043
Cell Tissue Res. 2015 Jun;360(3):439-56
pubmed: 25795143
J Immunol. 2008 Aug 1;181(3):1825-34
pubmed: 18641320
J Invest Dermatol. 2006 Dec;126(12):2621-30
pubmed: 16841036
Exp Cell Res. 2010 Feb 15;316(4):580-92
pubmed: 19818770
Nat Rev Dis Primers. 2017 May 11;3:17026
pubmed: 28492232
Br J Dermatol. 2017 Dec;177(6):1612-1618
pubmed: 28600798
Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12855-60
pubmed: 16908851
Autoimmunity. 2006 Nov;39(7):563-75
pubmed: 17101500

Auteurs

Desalegn Tadesse Egu (DT)

Chair of Vegetative Anatomy, Faculty of Medicine, Institute of Anatomy, LMU Munich, Munich, Germany.

Daniela Kugelmann (D)

Chair of Vegetative Anatomy, Faculty of Medicine, Institute of Anatomy, LMU Munich, Munich, Germany.

Jens Waschke (J)

Chair of Vegetative Anatomy, Faculty of Medicine, Institute of Anatomy, LMU Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH